2023-06-012024-05-312024-05-31false14101884BABAK MEDICAL LIMITED2024-08-2086220iso4217:GBPxbrli:pure141018842023-06-01141018842024-05-31141018842023-06-012024-05-31141018842022-05-11141018842023-05-31141018842022-05-112023-05-3114101884bus:SmallEntities2023-06-012024-05-3114101884bus:AuditExempt-NoAccountantsReport2023-06-012024-05-3114101884bus:AbridgedAccounts2023-06-012024-05-3114101884bus:PrivateLimitedCompanyLtd2023-06-012024-05-3114101884core:WithinOneYear2024-05-3114101884core:AfterOneYear2024-05-3114101884core:WithinOneYear2023-05-3114101884core:AfterOneYear2023-05-3114101884core:ShareCapital2024-05-3114101884core:SharePremium2024-05-3114101884core:RevaluationReserve2024-05-3114101884core:OtherReservesSubtotal2024-05-3114101884core:RetainedEarningsAccumulatedLosses2024-05-3114101884core:ShareCapital2023-05-3114101884core:SharePremium2023-05-3114101884core:RevaluationReserve2023-05-3114101884core:OtherReservesSubtotal2023-05-3114101884core:RetainedEarningsAccumulatedLosses2023-05-3114101884core:LandBuildings2024-05-3114101884core:PlantMachinery2024-05-3114101884core:Vehicles2024-05-3114101884core:FurnitureFittings2024-05-3114101884core:OfficeEquipment2024-05-3114101884core:NetGoodwill2024-05-3114101884core:IntangibleAssetsOtherThanGoodwill2024-05-3114101884core:ListedExchangeTraded2024-05-3114101884core:UnlistedNon-exchangeTraded2024-05-3114101884core:LandBuildings2023-05-3114101884core:PlantMachinery2023-05-3114101884core:Vehicles2023-05-3114101884core:FurnitureFittings2023-05-3114101884core:OfficeEquipment2023-05-3114101884core:NetGoodwill2023-05-3114101884core:IntangibleAssetsOtherThanGoodwill2023-05-3114101884core:ListedExchangeTraded2023-05-3114101884core:UnlistedNon-exchangeTraded2023-05-3114101884core:LandBuildings2023-06-012024-05-3114101884core:PlantMachinery2023-06-012024-05-3114101884core:Vehicles2023-06-012024-05-3114101884core:FurnitureFittings2023-06-012024-05-3114101884core:OfficeEquipment2023-06-012024-05-3114101884core:NetGoodwill2023-06-012024-05-3114101884core:IntangibleAssetsOtherThanGoodwill2023-06-012024-05-3114101884core:ListedExchangeTraded2023-06-012024-05-3114101884core:UnlistedNon-exchangeTraded2023-06-012024-05-3114101884core:MoreThanFiveYears2023-06-012024-05-3114101884core:Non-currentFinancialInstruments2024-05-3114101884core:Non-currentFinancialInstruments2023-05-3114101884dpl:CostSales2023-06-012024-05-3114101884dpl:DistributionCosts2023-06-012024-05-3114101884core:LandBuildings2023-06-012024-05-3114101884core:PlantMachinery2023-06-012024-05-3114101884core:Vehicles2023-06-012024-05-3114101884core:FurnitureFittings2023-06-012024-05-3114101884core:OfficeEquipment2023-06-012024-05-3114101884dpl:AdministrativeExpenses2023-06-012024-05-3114101884core:NetGoodwill2023-06-012024-05-3114101884core:IntangibleAssetsOtherThanGoodwill2023-06-012024-05-3114101884dpl:GroupUndertakings2023-06-012024-05-3114101884dpl:ParticipatingInterests2023-06-012024-05-3114101884dpl:GroupUndertakingscore:ListedExchangeTraded2023-06-012024-05-3114101884core:ListedExchangeTraded2023-06-012024-05-3114101884dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-06-012024-05-3114101884core:UnlistedNon-exchangeTraded2023-06-012024-05-3114101884dpl:CostSales2022-05-112023-05-3114101884dpl:DistributionCosts2022-05-112023-05-3114101884core:LandBuildings2022-05-112023-05-3114101884core:PlantMachinery2022-05-112023-05-3114101884core:Vehicles2022-05-112023-05-3114101884core:FurnitureFittings2022-05-112023-05-3114101884core:OfficeEquipment2022-05-112023-05-3114101884dpl:AdministrativeExpenses2022-05-112023-05-3114101884core:NetGoodwill2022-05-112023-05-3114101884core:IntangibleAssetsOtherThanGoodwill2022-05-112023-05-3114101884dpl:GroupUndertakings2022-05-112023-05-3114101884dpl:ParticipatingInterests2022-05-112023-05-3114101884dpl:GroupUndertakingscore:ListedExchangeTraded2022-05-112023-05-3114101884core:ListedExchangeTraded2022-05-112023-05-3114101884dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-05-112023-05-3114101884core:UnlistedNon-exchangeTraded2022-05-112023-05-3114101884core:NetGoodwill2024-05-3114101884core:IntangibleAssetsOtherThanGoodwill2024-05-3114101884core:LandBuildings2024-05-3114101884core:PlantMachinery2024-05-3114101884core:Vehicles2024-05-3114101884core:FurnitureFittings2024-05-3114101884core:OfficeEquipment2024-05-3114101884core:AfterOneYear2024-05-3114101884core:WithinOneYear2024-05-3114101884core:ListedExchangeTraded2024-05-3114101884core:UnlistedNon-exchangeTraded2024-05-3114101884core:ShareCapital2024-05-3114101884core:SharePremium2024-05-3114101884core:RevaluationReserve2024-05-3114101884core:OtherReservesSubtotal2024-05-3114101884core:RetainedEarningsAccumulatedLosses2024-05-3114101884core:NetGoodwill2023-05-3114101884core:IntangibleAssetsOtherThanGoodwill2023-05-3114101884core:LandBuildings2023-05-3114101884core:PlantMachinery2023-05-3114101884core:Vehicles2023-05-3114101884core:FurnitureFittings2023-05-3114101884core:OfficeEquipment2023-05-3114101884core:AfterOneYear2023-05-3114101884core:WithinOneYear2023-05-3114101884core:ListedExchangeTraded2023-05-3114101884core:UnlistedNon-exchangeTraded2023-05-3114101884core:ShareCapital2023-05-3114101884core:SharePremium2023-05-3114101884core:RevaluationReserve2023-05-3114101884core:OtherReservesSubtotal2023-05-3114101884core:RetainedEarningsAccumulatedLosses2023-05-3114101884core:NetGoodwill2022-05-1114101884core:IntangibleAssetsOtherThanGoodwill2022-05-1114101884core:LandBuildings2022-05-1114101884core:PlantMachinery2022-05-1114101884core:Vehicles2022-05-1114101884core:FurnitureFittings2022-05-1114101884core:OfficeEquipment2022-05-1114101884core:AfterOneYear2022-05-1114101884core:WithinOneYear2022-05-1114101884core:ListedExchangeTraded2022-05-1114101884core:UnlistedNon-exchangeTraded2022-05-1114101884core:ShareCapital2022-05-1114101884core:SharePremium2022-05-1114101884core:RevaluationReserve2022-05-1114101884core:OtherReservesSubtotal2022-05-1114101884core:RetainedEarningsAccumulatedLosses2022-05-1114101884core:AfterOneYear2023-06-012024-05-3114101884core:WithinOneYear2023-06-012024-05-3114101884core:Non-currentFinancialInstrumentscore:CostValuation2023-06-012024-05-3114101884core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-012024-05-3114101884core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-012024-05-3114101884core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-012024-05-3114101884core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-012024-05-3114101884core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-012024-05-3114101884core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-012024-05-3114101884core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-012024-05-3114101884core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-012024-05-3114101884core:Non-currentFinancialInstrumentscore:CostValuation2024-05-3114101884core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-05-3114101884core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-05-3114101884core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-05-3114101884core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-05-3114101884core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-05-3114101884core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-05-3114101884core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-05-3114101884core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-05-3114101884core:Non-currentFinancialInstrumentscore:CostValuation2023-05-3114101884core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-05-3114101884core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-05-3114101884core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-05-3114101884core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-05-3114101884core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-05-3114101884core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-05-3114101884core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-05-3114101884core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-05-3114101884bus:Director12023-06-012024-05-31

BABAK MEDICAL LIMITED

Registered Number
14101884
(England and Wales)

Unaudited Financial Statements for the Year ended
31 May 2024

BABAK MEDICAL LIMITED
Company Information
for the year from 1 June 2023 to 31 May 2024

Director

DANESHMAND, Babak

Registered Address

8b Accommodation Road
Golders Green
London
NW11 8ED

Registered Number

14101884 (England and Wales)
BABAK MEDICAL LIMITED
Statement of Financial Position
31 May 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets35,4622,648
5,4622,648
Current assets
Cash at bank and on hand160,77578,501
160,77578,501
Creditors amounts falling due within one year4(71,894)(50,566)
Net current assets (liabilities)88,88127,935
Total assets less current liabilities94,34330,583
Accruals and deferred income(1,200)(1,200)
Net assets93,14329,383
Capital and reserves
Called up share capital130100
Profit and loss account93,01329,283
Shareholders' funds93,14329,383
The financial statements were approved and authorised for issue by the Director on 20 August 2024, and are signed on its behalf by:
DANESHMAND, Babak
Director
Registered Company No. 14101884
BABAK MEDICAL LIMITED
Notes to the Financial Statements
for the year ended 31 May 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
2.Average number of employees

20242023
Average number of employees during the year11
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 June 232,648
Additions4,635
At 31 May 246,344
Depreciation and impairment
Charge for year1,821
At 31 May 24883
Net book value
At 31 May 245,462
At 31 May 232,648
4.Creditors: amounts due within one year

2024

2023

££
Taxation and social security26,8119,193
Other creditors45,08341,373
Total71,89450,566